Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Caribou Biosciences Q2 Earnings

  Caribou Biosciences (NASDAQ:CRBU) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Caribou Biosciences (NASDAQ:CRBU) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Caribou Biosciences missed estimated earnings by 22.22%, reporting an EPS of $-0.44 versus an estimate of $-0.36.

Revenue was up $2.72 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 9.3% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Caribou Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Exxon Mobil Q3 Earnings

By Benzinga Insights
Today, 2:11 AM
Exxon Mobil (NYSE:XOM) reported its Q3 earnings results on Friday, October 28, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Exxon Mobil beat estimated earnings by 21.92%, reporting an EPS of $4.45 versus an estimate of $3.65.

XOM

Read More

Earnings Preview: Myovant Sciences

By Benzinga Insights
Today, 2:11 AM
Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Myovant Sciences will report an earnings per share (EPS) of $-0.57.

MYOV